Dynavox Group AB (publ) (TDVXF)
OTCMKTS · Delayed Price · Currency is USD
9.48
-0.48 (-4.85%)
Feb 9, 2026, 1:07 PM EST
Dynavox Group AB Revenue
In the year 2025, Dynavox Group AB had annual revenue of 2.47B SEK with 25.10% growth. Dynavox Group AB had revenue of 677.00M in the quarter ending December 31, 2025, with 15.71% growth.
Revenue
2.47B SEK
Revenue Growth
+25.10%
P/S Ratio
3.54
Revenue / Employee
2.45M SEK
Employees
1,005
Market Cap
947.42M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.47B | 494.90M | 25.10% |
| Dec 31, 2024 | 1.97B | 358.80M | 22.24% |
| Dec 31, 2023 | 1.61B | 396.90M | 32.63% |
| Dec 31, 2022 | 1.22B | 344.80M | 39.56% |
| Dec 31, 2021 | 871.60M | -23.60M | -2.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Meihua International Medical Technologies | 89.55M |
| Encision | 6.30M |
| Lancer Orthodontics | 6.19M |
| Reflect Scientific | 1.72M |
| Ozop Energy Solutions | 323.50K |
| Standard Dental Labs | 306.82K |
| Hear AtLast Holdings | 93.20K |
| Cardiac Biotech Solutions | 50.37K |
Dynavox Group AB News
- 4 months ago - Dynavox Group AB (publ) (TDVXF) Q3 2025 Earnings Call Transcript - Seeking Alpha